BUZZ - AbbVie shares rise after raising full-year profit forecast

October 30 - ** Pharmaceutical company AbbVie ABBV.N shares rose 1.5% to $294.79; hitting a record high

** Forecasts (link) adjusted earnings per share (EPS) for the fiscal year at $13.95 to $13.99, previously expected at $13.76 to $13.96

** According to data compiled by London Stock Exchange Group (LSEG), the company reported third-quarter earnings per share of $3.82, beating analysts' expectations of $3.75

** Out of 32 brokers, 26 rate the stock as “buy” or higher, and 6 rate it as “hold”; median target price is $289—data compiled by LSEG

** Including intraday moves, the stock is up about 30% so far this year

(To assist non-English speakers, Reuters automatically translates its reports into several other languages. Because automated translation may contain errors or lack necessary context, Reuters does not guarantee the accuracy of automated translation texts. Automated translations are provided solely for the convenience of readers. Reuters accepts no liability for any damage or loss caused by the use of automated translation functionality.)